1h59: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
New page: left|200px<br /> <applet load="1h59" size="450" color="white" frame="true" align="right" spinBox="true" caption="1h59, resolution 2.1Å" /> '''COMPLEX OF IGFBP-5 W...
 
No edit summary
Line 1: Line 1:
[[Image:1h59.gif|left|200px]]<br />
[[Image:1h59.gif|left|200px]]<br /><applet load="1h59" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="1h59" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="1h59, resolution 2.1&Aring;" />
caption="1h59, resolution 2.1&Aring;" />
'''COMPLEX OF IGFBP-5 WITH IGF-I'''<br />
'''COMPLEX OF IGFBP-5 WITH IGF-I'''<br />


==Overview==
==Overview==
Insulin-like growth factors (IGFs) are key regulators of cell, proliferation, differentiation and transformation, and are thus pivotal in, cancer, especially breast, prostate and colon neoplasms. They are also, important in many neurological and bone disorders. Their potent mitogenic, and anti-apoptotic actions depend primarily on their availability to bind, to the cell surface IGF-I receptor. In circulation and interstitial, fluids, IGFs are largely unavailable as they are tightly associated with, IGF-binding proteins (IGFBPs) and are released after IGFBP proteolysis., Here we report the 2.1 A crystal structure of the complex of IGF-I bound, to the N-terminal IGF-binding domain of IGFBP-5 (mini-IGFBP-5), a, prototype interaction for all N-terminal domains of the IGFBP family. The, principal interactions in the complex comprise interlaced hydrophobic side, chains that protrude from both IGF-I and the IGFBP-5 fragment and a, surrounding network of polar interactions. A solvent-exposed hydrophobic, patch is located on the IGF-I pole opposite to the mini-IGFBP-5 binding, region and marks the IGF-I receptor binding site.
Insulin-like growth factors (IGFs) are key regulators of cell proliferation, differentiation and transformation, and are thus pivotal in cancer, especially breast, prostate and colon neoplasms. They are also important in many neurological and bone disorders. Their potent mitogenic and anti-apoptotic actions depend primarily on their availability to bind to the cell surface IGF-I receptor. In circulation and interstitial fluids, IGFs are largely unavailable as they are tightly associated with IGF-binding proteins (IGFBPs) and are released after IGFBP proteolysis. Here we report the 2.1 A crystal structure of the complex of IGF-I bound to the N-terminal IGF-binding domain of IGFBP-5 (mini-IGFBP-5), a prototype interaction for all N-terminal domains of the IGFBP family. The principal interactions in the complex comprise interlaced hydrophobic side chains that protrude from both IGF-I and the IGFBP-5 fragment and a surrounding network of polar interactions. A solvent-exposed hydrophobic patch is located on the IGF-I pole opposite to the mini-IGFBP-5 binding region and marks the IGF-I receptor binding site.


==Disease==
==Disease==
Line 11: Line 10:


==About this Structure==
==About this Structure==
1H59 is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1H59 OCA].  
1H59 is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1H59 OCA].  


==Reference==
==Reference==
Line 17: Line 16:
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Protein complex]]
[[Category: Protein complex]]
[[Category: Beisel, H.G.]]
[[Category: Beisel, H G.]]
[[Category: Engh, R.A.]]
[[Category: Engh, R A.]]
[[Category: Holak, T.A.]]
[[Category: Holak, T A.]]
[[Category: Huber, R.]]
[[Category: Huber, R.]]
[[Category: Kalus, W.]]
[[Category: Kalus, W.]]
Line 28: Line 27:
[[Category: insulin-like growth factor]]
[[Category: insulin-like growth factor]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 17:13:02 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 12:57:32 2008''

Revision as of 13:57, 21 February 2008

File:1h59.gif


1h59, resolution 2.1Å

Drag the structure with the mouse to rotate

COMPLEX OF IGFBP-5 WITH IGF-I

OverviewOverview

Insulin-like growth factors (IGFs) are key regulators of cell proliferation, differentiation and transformation, and are thus pivotal in cancer, especially breast, prostate and colon neoplasms. They are also important in many neurological and bone disorders. Their potent mitogenic and anti-apoptotic actions depend primarily on their availability to bind to the cell surface IGF-I receptor. In circulation and interstitial fluids, IGFs are largely unavailable as they are tightly associated with IGF-binding proteins (IGFBPs) and are released after IGFBP proteolysis. Here we report the 2.1 A crystal structure of the complex of IGF-I bound to the N-terminal IGF-binding domain of IGFBP-5 (mini-IGFBP-5), a prototype interaction for all N-terminal domains of the IGFBP family. The principal interactions in the complex comprise interlaced hydrophobic side chains that protrude from both IGF-I and the IGFBP-5 fragment and a surrounding network of polar interactions. A solvent-exposed hydrophobic patch is located on the IGF-I pole opposite to the mini-IGFBP-5 binding region and marks the IGF-I receptor binding site.

DiseaseDisease

Known disease associated with this structure: Growth retardation with deafness and mental retardation due to IGF1 deficiency OMIM:[147440]

About this StructureAbout this Structure

1H59 is a Protein complex structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.

ReferenceReference

The interaction of insulin-like growth factor-I with the N-terminal domain of IGFBP-5., Zeslawski W, Beisel HG, Kamionka M, Kalus W, Engh RA, Huber R, Lang K, Holak TA, EMBO J. 2001 Jul 16;20(14):3638-44. PMID:11447105

Page seeded by OCA on Thu Feb 21 12:57:32 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA